Hospitals and clinics
The goal is to protect continuity of care, especially against ransomware, and to protect patient data and medical devices.
/ HEALTHCARE
In healthcare, cybersecurity is a patient-safety issue: a system outage or a tampered medical device can affect lives. Our security testing shows where your organization is vulnerable, without disrupting patient care.
[ 01 ] / WHAT IT IS
The purpose of healthcare security testing is to show that a healthcare organization's or medical device manufacturer's systems, devices and data are protected against attack, so that continuity of care, patient safety and the confidentiality of health data are not at risk, and that the organization meets NIS2, GDPR and medical device regulatory expectations.
Healthcare is one of the most frequently attacked sectors: health data is highly valuable, continuity of care is critical, and organizations often have limited security resources. A ransomware attack on a hospital is not only a business problem: it can lead to delayed care, postponed surgery and risk to patients. So the purpose of testing here is first of all to safeguard continuity of care, patient safety and health data.
The healthcare environment is unusual: there are many medical devices (imaging systems, infusion pumps, monitors), often running old operating systems, impossible to patch and intolerant of conventional testing. Standard protocols (HL7, FHIR, DICOM) and national integrations (for example electronic health record platforms) form their own attack surface. Testing is therefore cautious, using methods that do not disrupt care, passive where necessary or in a test environment.
The regulatory landscape is tough too. NIS2 classifies healthcare as a highly critical sector, GDPR protects health data as a special category of personal data, the EU MDR and IVDR set cybersecurity expectations for medical devices, and IEC 81001-5-1 describes secure development of health software. Testing provides evidence that controls work. The method builds on penetration testing and vulnerability assessment. This is not legal advice: confirm regulatory obligations with legal counsel.
Regulation and standards
[ 02 ] / WHO IT'S FOR
In healthcare the purpose differs by role, but patients are always at the center.
The goal is to protect continuity of care, especially against ransomware, and to protect patient data and medical devices.
The goal is to demonstrate device cybersecurity for market access (EU MDR/IVDR) and to customers, by catching flaws early in development.
The goal is to evidence the security of hospital information systems, patient portals and integrations (HL7, FHIR) to customers and auditors.
The goal is to protect sample and result data, and to secure automated lab equipment and the systems connected to it.
The goal is to protect health data and show practical GDPR compliance, with a manageable scope and cost.
The goal is to verify the security of telemedicine, mobile apps and wearable-linked services, and the protection of health data.
[ 03 ] / WHAT'S INCLUDED
We tailor the scope to your organization and its continuity-of-care requirements, in agreement with clinical and IT operations teams.
The hospital information system (HIS), PACS, laboratory systems, network segmentation, access management and attack paths.
Network connections, default credentials, services and firmware of devices, assessed from a patient-safety standpoint and with cautious methods.
Security assessment of HL7, FHIR and DICOM, and of integrations with national health systems.
Authentication and privacy testing of web and mobile apps and APIs that handle health data.
We simulate typical ransomware attack paths and check backups, segmentation, detection and recoverability.
Assessment of cloud and provider environments that hold health data. See cloud security.
We review access to personal health data, logging, and protection against unauthorized viewing.
Security review of healthcare software and device code during development. See source code review.
[ 04 ] / HOW IT WORKS
Above all, the process protects patient care: testing must never conflict with patient safety.
With clinical and IT operations leaders we decide what and when we can test, which systems are life-critical, and what stop conditions apply.
We map devices and the network without disturbing care, using passive observation and documents.
Where possible we test in a test environment or in coordination with the manufacturer. On live systems we test in agreed windows under strict rules.
We rate findings by their effect on patient safety, continuity of care and data protection.
You receive executive and technical reports and practical recommendations that respect clinical operating constraints (for example compensating protection for unpatchable devices).
After fixes we verify the result and recommend regular testing and continuous monitoring.
[ 05 ] / WHAT IT SOLVES
In healthcare, the cost of downtime cannot be measured in money alone. Testing shows where an attack could halt patient care and which data is at risk, so that limited resources can go to the most important defenses.
It also gives regulators, auditors, partners and patients evidence that you protect your systems and health data in practice, in line with NIS2 and GDPR. For medical device makers it provides evidence needed for market access.
[ 06 ] / WHY QYNTAR
Because in healthcare, caution and respect for patient safety matter even more than technical skill.
We work with passive methods, test environments and agreed rules so that testing never disrupts care.
We know the quirks of clinical systems and medical devices, so our recommendations work within real operational limits.
We shape the report so it maps to the evidence needs of NIS2, GDPR and medical device regulation.
From testing to incident response and compliance support, you can work with a single partner. See incident response.
[ 07 ] / FAQ
To show that healthcare systems, devices and data are protected, so that continuity of care, patient safety and the confidentiality of health data are not at risk, and that the organization meets regulatory expectations.
The methodology exists to prevent that: passive observation, test environments, agreed windows and stop conditions, with life-critical systems handled with extra care. We do not disturb live patient care.
Yes, with care. Because of patient safety we agree testing with the manufacturer, biomedical engineers and clinical leaders. For many devices a passive or lab-based assessment is appropriate, and we do not actively attack a device that is connected to a patient.
NIS2 classifies healthcare as a highly critical sector. Whether you are in scope depends on your size and activity. See NIS2 compliance. This is not legal advice.
The EU regulations on medical devices and in vitro diagnostic devices expect manufacturers to design and operate devices securely, including managing cybersecurity risk. Testing supports the manufacturer's evidence, while conformity assessment is carried out by the body the regulation names.
With compensating controls: network segmentation, access restriction, hardening, monitoring and a recovery plan. The test shows where they are needed. See hardening.
From a few days to several weeks depending on the organization's size and scope. Coordination and clarifying the patient-safety conditions often take longer than the testing itself. We give a schedule after scoping.
[ 08 ] / RELATED SERVICES
From a specific technical issue to a complex security project, we can help you find the way forward.